Roivant Sciences (ROIV) Return on Invested Capital [ROIC] (2021 - 2024)
Roivant Sciences (ROIV) posted Return on Invested Capital [ROIC] of 71.76% for fiscal Q1 2025 (quarter ended Jun 30, 2024), up 125.55 percentage points from -53.79% a year earlier and up 6.21 percentage points from the prior quarter.
Roivant Sciences (ROIV) Return on Invested Capital [ROIC] (2021 - 2024) Analysis & Trends
For FY2024 (ended Mar 31, 2024), Roivant Sciences' Return on Invested Capital [ROIC] came in at 105.84%, up 150.54 percentage points from FY2023.
- In prior fiscal years, Roivant Sciences' Return on Invested Capital [ROIC] was -44.70% in FY2023 (+15.93 pp) and -60.63% in FY2022.
- Quarterly Return on Invested Capital [ROIC] has run from a low of -73.29% in fiscal Q1 2023 to a high of 111.48% in fiscal Q3 2024 over five years.
- On a year-over-year basis, Return on Invested Capital [ROIC] has increased in each of the last six quarters, with an average year-over-year change of +57.27 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Invested Capital [ROIC] in the past five years was fiscal Q3 2024, with a gain of 184.12 percentage points; the weakest was fiscal Q1 2023, with a drop of 22.26 percentage points.
- According to Business Quant data, Return on Invested Capital [ROIC] for the three prior fiscal quarters was 65.55% (Q4 2024), 111.48% (Q3 2024) and -54.15% (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 30.89% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.28% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.52% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 23.11% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 15.60% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.11% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 12.34% |
| 10 | Roivant Sciences | 29.81 Bn | 13.51 Bn | 31.77 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 71.76% |
| Mar 31, 2024 | 65.55% |
| Dec 31, 2023 | 111.48% |
| Sep 30, 2023 | -54.15% |
| Jun 30, 2023 | -53.79% |
| Mar 31, 2023 | -52.86% |
| Dec 31, 2022 | -72.64% |
| Sep 30, 2022 | -55.52% |
| Jun 30, 2022 | -66.93% |
| Mar 31, 2022 | -57.51% |
| Dec 31, 2021 | -64.01% |
| Sep 30, 2021 | -68.68% |
| Jun 30, 2021 | -51.03% |
Roivant Sciences Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();